Results 301 to 310 of about 11,021,950 (406)

Editorial: Digital cognitive behavior therapy for obsessive-compulsive disorder. [PDF]

Front Hum Neurosci
Chakrabarti S.
europepmc   +1 more source

Time, the final frontier

Molecular Oncology, EarlyView.
This article advocates integrating temporal dynamics into cancer research. Rather than relying on static snapshots, researchers should increasingly consider adopting dynamic methods—such as live imaging, temporal omics, and liquid biopsies—to track how tumors evolve over time.
Gautier Follain, Michal Dibus, Omkar Joshi, Guillaume Jacquemet   +3 more
wiley   +1 more source

Long-term follow-up of acceptance-enhanced behavior therapy for trichotillomania. [PDF]

Psychiatry Res
Barber KE, Woods DW, Ely LJ, Saunders SM, Compton SN, Neal-Barnett A, Franklin ME, Capriotti MR, Conelea CA, Twohig MP.   +9 more
europepmc   +1 more source

A Primary Care “Friendly” Cognitive Behavioral Insomnia Therapy

, 2003
Jack D. Edinger, William S. Sampson
openalex   +1 more source

Interplay of integrins and selectins in metastasis

Molecular Oncology, EarlyView.
Here we review the role of integrins and their interplay with selectins in metastasis. The efficacy of integrin‐targeted therapies may be reduced in tumors where metastasis relies heavily on selectins. In certain tumors, integrins and selectins exhibit a synergistic interaction during intraperitoneal dissemination.
Diana Maltseva, Ashot Nersisyan, Alexander Tonevitsky   +2 more
wiley   +1 more source

Comparative analysis of cognitive behavioral therapy and dialectical behavior therapy in enhancing psychological capital among medical students: a randomized controlled trial. [PDF]

Front Psychol
Dong C, Zhao J, Wei Y, Wu D, Cai Z.
europepmc   +1 more source

Effects of animal-assisted therapy on agitated behaviors and social interactions of older adults with dementia

, 2003
Nancy E. Richeson
openalex   +1 more source

Practice of Behavior Therapy (Chapter 6 from The Human Reflex)

, 1981
Bufford, Rodger K
core  

Inhibitor of DNA binding‐1 is a key regulator of cancer cell vasculogenic mimicry

Molecular Oncology, EarlyView.
Elevated expression of transcriptional regulator inhibitor of DNA binding 1 (ID1) promoted cancer cell‐mediated vasculogenic mimicry (VM) through regulation of pro‐angiogenic and pro‐cancerous genes (e.g. VE‐cadherin (CDH5), TIE2, MMP9, DKK1). Higher ID1 expression also increased metastases to the lung and the liver.
Emma J. Thompson, Emma L. Dorward, Kristyn Jurrius, Nathalie Nataren, Markus Tondl, Kay K. Myo Min, Michaelia P. Cockshell, Anahita Fouladzadeh, John Toubia, Mark DeNichilo, Delphine Merino, Claudine S. Bonder   +11 more
wiley   +1 more source

Evaluation of dialectical behavior therapy for adolescents in routine clinical practice: a pre-post study. [PDF]

BMC Psychiatry
Syversen AM, Schønning V, Fjellheim GS, Elgen I, Wergeland GJ.   +4 more
europepmc   +1 more source